chrisvoncsefalvay/vaers-outcomes huggingface dataset:
side effects were pretty intense,lasting for the most part of 3 weeks/massive hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (side effects were pretty intense,lasting for the most part of 3 weeks/massive hair loss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (side effects were pretty intense,lasting for the most part of 3 weeks/massive hair loss). The patient was treated with MULTIVITAMIN & MINERAL at a dose of UNK dosage form; B-COMPLEX 2000 at a dose of 1 UNK; CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) at a dose of UNK dosage form and COLLAGEN at a dose of UNK dosage form. At the time of the report, ALOPECIA (side effects were pretty intense,lasting for the most part of 3 weeks/massive hair loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Patient stated that events started from beginning of Feb-2021.Patient stated that she had lost at least 1/3 of her volume and had massive  breakage throughout. She stated that she had  very long and healthy hair before vaccine. Patient stated that she had no genetic conditions or predisposition to alopecia or hair loss.
Had flu like symptoms, felt weak, left arm was sore, swollen and red. Monday was when I developed swollen lymph nodes on the left side of my neck and underarm. I was prescribed Keflex 500mg, Motrin 600mg, Zyrtec and Flonase. Then taken off of Keflex and prescribed Prednisone 20mg.   --Veronica Mosqueda
6JAN93 w/4th vax pt had sz-no temp; awake on & off all noc long; 1105AM had 10 mins staring sz; very sleepy afterwards; p/experiencing approx 60 szs until age of 20 months, pt exp a 3 hrs sz, shock & died; autopsy was inconclusive;
Patient became very tense with rigid muscle upon needle insertion.  After some vaccine was instilled there was too much resistance to instill further.  Very small (difficult to measure <0.1mL) in syringe after needle removed therefore less than full volume administered to patient.
Bell's Palsy was diagnosed when I  went in  to the ER at CRMC. Drooping right eye and mouth. not able to close right eye.
pain; Information was received from a lawyer and a currently 65 year old male via a fact Sheet for zoster vaccine live (ZOSTAVAX) (see case # US-009507513-1801USA002349).  Within the Fact Sheet, the pt was asked to identify all vaccines that he had received.  He responded that he received a vaccine for pneumonia (manufacturer not specified) on an unspecified date.  When asked if he experienced any adverse reactions or side effects, he responded "pain."  The outcome of the events was unknown.  Causality assessment was related.  This is one of two reports referring to the same patient.; Sender's Comments:  US-009507513-1801USA002349:
Cellulitis; arm swollen; Redness in the Injection site; Swelling in the Injection site; This case was reported by a other health professional via call center representative and described the occurrence of cellulitis in a 16-year-old patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA201A, expiry date 30th October 2020), (batch number AMVA206A, expiry date 13th November 2020) and (batch number AMVA323A, expiry date 31st March 2020) for prophylaxis.   On 11th August 2020, the patient received Menveo. In August 2020, less than a day after receiving Menveo, the patient experienced cellulitis (serious criteria GSK medically significant), extensive swelling of vaccinated limb, injection site erythema and injection site swelling. On an unknown date, the outcome of the cellulitis, extensive swelling of vaccinated limb, injection site erythema and injection site swelling were unknown.   It was unknown if the reporter considered the cellulitis, extensive swelling of vaccinated limb, injection site erythema and injection site swelling to be related to Menveo.  Additional details were provided as follows: It was reported that, several patients had been experiencing redness and swelling in the injection site, whole arm swollen and cellulitis after receiving a dose of Menveo.  The symptoms were started within hours. The reporter was consented to follow up. The reporter did not know how many patients experienced the symptoms but agreed to follow up and look up the information.  The reporter only reported that one patient was 11 years old and other was 16 years old.  She reported 3 different lot numbers and expiration dates for the vaccines administered to different patients.  She had those details in hand because she was worried that the side effects were due to a lot issue. This was 1 of 3 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020159650:same reporter
This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date between 06-APR-2017 and 01-MAY-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9 lot # M016193, expiration date 24-APR-2018, intramuscularly (dose was not reported) in immunization series. There were no adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 34.5 degrees Fahrenheit for 1 hour and 53 minutes and of 34.7 degrees Fahrenheit for 1 hour and 25 minutes. There were no previous temperature excursions reported. A Digital Data Logger was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA000781: US-009507513-1705USA007705: US-009507513-1705USA007706: US-009507513-1705USA007707: US-009507513-1705USA007708: US-009507513-1705USA007709: US-009507513-1705USA007710: US-009507513-1705USA007711.
20-24 hours after the dose got erythematous, itchy rash to left flexural elbow crease and under eyes bilaterally with mild eyelid swelling.  It continued for a week and spread to some other areas of body including around right ear, right groin, left arm, bilateral hands. Itching better after benedryl and hydrocortisone 1% used. no known exposure to poisonous plants (ivy/ oak) but did have some linear erythematous marks within it
This spontaneous report as received from a 68 year old male patient refers to himself. Patient had no medical history not drug reactions/allergies. On 10-OCT-2014 the patient was vaccinated with a dose of ZOSTAVAX (dose:1 ml, "somewhere in the arm", lot# reported as 7002602200, expiration date: October 2015). Concomitant therapies included Lisinopril (manufacturer unknown) for high blood pressure. On 11-OCT-2014 the patient experienced change in color of his bowel movements. He reported that the color was a "Kelly green and unusual"  and lasted for 3 days (from 11-OCT-2014 to 13-OCT-2014). Hi did not seek medical attention. No treatment was given. The patient reported that the color change started to clear up around 13-OCT-2014 into 14-OCT-2014. Hi didn't experience any other symptoms. The outcome of the event was reported as recovering/resolving. Relatedness between the event and ZOSTAVAX was not provided. Additional information has been requested.
was seen by provider 03/11/2021 with swollen eyes, rash all over with some blisters. prednisone was given. eyes remain swollen somewhat and some rash, but better.
red blotches on my arms and upper chest; This is a spontaneous report from a non-contactable other health care professional. A 44-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EK9231), via an unspecified route of administration on 06Jan2021 at single dose at arm left for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 08Jan2021, the patient experiencing red blotches on my arms and upper chest. The patient did not receive treatment for the adverse event. The outcome of the events was not recovered.   No follow-up attempts are possible. No further information is expected.
Swollen and rash from shot, vomiting anything I eat, lymph node on left arm where I got 2nd sore swollen and painful, can?t keep any food down since Friday. Already lost 5 lbs, hard trouble breathing today. I took my Valium it didn?t help. My Arm still isn?t not feeling better or swelling going down or rash gone. Started around 5pm same day as shot
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Sep2021 at 14:00 as dose 3 (booster) single (Batch/Lot number: unknown), in right arm and on 17Feb2022 at 14:00 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Pre diabetic" (unspecified if ongoing); "arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (23Jun2022) Negative, notes: tested negative on 3rd day; (25Jun2022) Positive, notes: tested positive on day 5, again. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient's mother signed the consent form & requested that patient be vaccinated at the school based clinic. Patient received the influenza vaccine on 10-26-12. Mother called & reported that patient had received the flu vaccine a wk. prior during P.E. & she forgot to notify us to let us know.
Had severe arthritis develop in knees, lasting 8 months. Treated w/ physical therapy and massages and homeopathic medicine.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On 13-MAY-2015, the patient was vaccinated with an expired dose of (Oka/Merck) VARIVAX (lot # J005724, expiration date 08-MAY-2015) (dose and route of administration were not provided). No adverse events were reported. Additional information has been requested.
Mild headache, shivering, shaking, no appetite, pain in hips. Took a pain reliever to ease symptoms.
PATIENT WAS ASKED TO HAVE A SEAT IN THE WAITING AREA. MOM REPORTED THAT HE WAS NAUSEATED, HOT, PALE, AND FEELING FAINT. MOM LAID PATIENT ON THE FLOOR AND PROPPED FEET UP ON CHAIR. THE PATIENT REMAINED ON THE FLOOR UNITL EMS ARRIVED. PATIENT DID NOT LOSE CONSCIOUSNESS, BUT DID FEEL FAINT.
Zoster without complications  Valtrex 1gm q8hrs for 7 days that has been extended for 3 more days due to the persistence of the symptoms  Symptoms: nerve pain, red rash, burning sesnsation at the left part of the brain/face (specifically on the left forehead, eye, chick, ear and scalp).
First moderna vaccine 01.07.2021 uneventful. Second vaccine 02.06.2021. Experienced full compliment second vaccine symptoms of chills, shakes, aching, arthralgia, etc. lasting acutely approx. 4 days followed by 2 days less intense sx. Since this time have had persistent joint arthralgia that was not present before vaccine. Additionally pre-existing paresthesia's at right mastectomy and lymphectomy sites have become much more pronounced and painful. This increased nerve pain is not subsiding with time. Have received body work, taken OTCs and discussed w/ my providers. May resume gabapentin if arthralgia and paresthesia sx do not subside
The pt experienced hives, erythema multiforme on the chest and arms. Symptoms resolved within 36 hours.
Patients involved have not experienced any symptoms related to this adverse event at this time / No additional AE; Pharmacist calling to report adverse event regarding expired doses of PNEUMOVAX 23 that were inadvertently administered on 6/22/2023; This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported.  On 22-JUN-2023, the patient was inadvertently vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, 0.5 ml, once (lot number U022984 was verified to be valid, expiration date reported and confirmed as 29-JAN-2023) (route of administration and anatomical location were not provided) (Expired product administered). The patient did not experienced any symptoms related to this adverse event at this time.  This is one of two reports received from the same reporter. ; Sender's Comments:  US-009507513-2307USA011007:
rash around torso; This case was reported by a consumer via (Shingrix GSK chatbot) interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient for himself/herself. The age at vaccination was not reported. The patient received a dose of Shingrix shot and had rash around torso. The patient asked if you get a rash around your torso after 1st dose shot are you allergic to the vaccine. The patient asked should he/she get the 2nd dose. The follow up could not be possible as no contact details were available.
Chest pains; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pains). At the time of the report, CHEST PAIN (Chest pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment details were provided.
Seizure like activity, Loss of consciousness on 2/25/2009 see notes  4/27/09 Received hospital medical records of 2/26-2/27/2009. FINAL DX: seizure-like event Records reveal patient experienced approx 6-8 episodes of motor tics of moving head in cycles, right ear to right shoulder, cycles lasting approx 30 min over past 6 mo.  Night before admit had same sort of episode w/staring & blank expression, unresponsive to verbal stimuli, right leg drawn to chest in jerky movements lasting appro 20-30 min, then vomited, bowel & bladder incontinence, tired & fell asleep quickly.  Neuro consult done & found anxiety, slightly decreased tone & strength, truncal instability, slight tremor right more than left, mild delayed milestones.  No events while hospitalized.   D/c to home w/Neuro f/u, rx for diastat & video taping of events requested.
Heart beating fast Shortness of breath  Can hear my heart beat in my neck or other areas.
left arm hurt like someone punched my arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurt like someone punched my arm) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Allergy NOS, Polycystic ovarian syndrome and Thyroid disorder NOS. Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for Allergy NOS, LABETALOL HYDROCHLORIDE (LABETALOL [LABETALOL HYDROCHLORIDE]) and FOSINOPRIL for Hypertension, METFORMIN HYDROCHLORIDE (METFORMIN ER) for Polycystic ovarian syndrome, DULAGLUTIDE (TRULICITY) for Polycystic ovary, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced PAIN IN EXTREMITY (left arm hurt like someone punched my arm) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg and IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 200 mg three times a day. On 09-May-2021, PAIN IN EXTREMITY (left arm hurt like someone punched my arm) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Just after 3:00 am, I was very nauseous, vomiting repeatedly while every bone and muscle ached severely.  My stomach muscles went into spasms and my head felt like what i imagine a migraine feels like. The pain behind my left eye was severe. My left  side of neck felt like there was a knot and it took all my strength to try to massage it felt like no blood was moving. Strangest feeling I have ever had. Went from chills to sweats every 3-4 minute cycles. Did not feel like I had a fever though. I am 0 - blood type if that matters. Day 2 all but body aches are gone.
Fever 100 at 24hrs after shot  Chills 6hrs Aches 24 hrs Joint pain  24 hrs Brain fog 1-2 days
I63.511 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY 2/3/2022 ACUTE STROKE DUE TO OCCLUSION OF RIGHT MIDDLE CEREBRAL ARTERY
Approximately 2 weeks after vaccination,  injection site became red, warm to touch, itchy, and swollen, and painful to touch.  Area was approximately 2 3/4" long, and 2" wide.  Instructed patient to follow up with her PCP.  She was instructed to place ice over area.
This spontaneous report as received from a health care worker refers to a 41 week old patient. On 20-AUG-2013, the patient was vaccinated with the third dose of ROTATEQ (route and lot # not reported). No adverse effect was reported. Additional information has been requested.
In addition to feeling tired, I was suddenly presented with a strong smell of smoke, which continued constantly without stopping at any time of the day, in fact its still present till this day.
Patient stated that the day after receiving the Moderna vaccine he started having issues with his vision and issues seeing color. Patient also states he felt like his body was locking up and aching all over. Pt started having rash on his arm today (4 days post injection).
Initial information received on 20-Dec-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves 3 patients of unknown demography who received deteriorated vaccine IPOL (lot N1J451M and expiry date 05-Oct-2019) of which some opened and some unopened was left at 48F for 102 hours, via route in unknown administration site on an unknown date. The patients' past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was a case of actual medication error due to incorrect product storage. It was not reported if the patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Vaccine was administered Wednesday 4/7/21 at 8:00am, 24 hours later, woke up with a sore throat. By Friday 4/16 pain in the throat reached a level 10. unable to talk, open mouth, or swallow without being in severe pain. 4/16 made an appointment at clinic because the pain was unbearable.  did a strep test and COVID test.  Results: strep test: NEGATIVE COVID test: POSITIVE pain in throat continued to increase with all of the same symptoms as previously stated previously.  started on amoxicillin 4/11 for infection in his thorat
grandma devel rash p/ grandson was vaccinated w/ chickenpox vax;her tongue was swollen;breaking out w/ chickenpox on face;open sore;low grade fever w/ 3 blister on abd & 1 blister on leg;low grade fever for 2 wks complicated by dehydration
Fever, loss of taste, loss of smell, headache, deep cough, and body aches, starting on 9/25/21.
Pt said he felt kind of weak after the vaccine shot on Sunday but can still walk to bed. Waking up on Monday, he could not walk. He could not sit up due to hip muscle weakness. Later on Monday, he developed a fever with a T-max of 101.6 °F.  MRI C/T/L spine demonstrated cauda equine nerve root enhancement, lumbar puncture w/ protein 58 and lymphocytic pleocytosis (atypical for GBS), patient was started on IVIg (had infusion reaction) and switched to PLEX (s/p 3 sessions) with clinical improvement. At time of discharge, was able to walk with a walker.
ABOUT 2 MINUTES AFTER VACCINATION PATIENT SAID HE WAS FEELING WARMTH TO HIS FACE , SWEATY , DIFFICULTY BREATHING STILL ALERT.  CALLED 911 AND I TOLD HIM THAT I WAS GOING TO GIVE HIM AN EPIPEN. A FEW MINUTES AFTER THE EPIPEN HE SAID HE WAS FEELING BETTER.
pt screamed for hrs evening of shots 16SEP93; rt leg was swollen 20SEp93 pt devel URI & was seen by MD;
Pt states his eye has been twitching and lips have been swollen. Onset started shortly after administration of flu vaccine according to pt. He denies use of any new medications or ingestion of dietary substances that may have caused an allergic rxn.
Slight fever of 100; Chills; slight headache; Tiredness; Body weakness; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3248), in right arm on 24Mar2021 at 13:15 (at the age of 44-year-old), as single dose for COVID-19 immunisation. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3248), in right arm on 03Mar2021 at 15:30 (at the age of 44-year-old), as single dose for COVID-19 immunisation. Medical history of the patient was reported as not applicable. Patient had no known allergies to medications, food or other products. The patient did not receive any other medication within 2 weeks of vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. It was unsure whether, prior to vaccination the patient was not diagnosed with COVID-19. Since vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 21:00, the patient experienced slight fever (100), chills, slight headache and body weakness/tiredness. No therapeutic measures were taken for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events slight fever, chills, slight headache and body weakness/tiredness were recovering at the time of report.   No follow-up attempts are needed. No further information is expected.